Cite
HARVARD Citation
Donnez, J. et al. (2022). Linzagolix With and Without Hormonal Add-Back Therapy for the Treatment of Symptomatic Uterine Fibroids: Two Randomized, Placebo-Controlled, Phase 3 Trials. Obstetrical & gynecological survey. 77 (12), pp. 741-742. [Online].